Monogram Orthopaedics Ownership
| MGRM Stock | 2.02 0.02 1.00% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Monogram |
Monogram Stock Ownership Analysis
About 34.0% of the company outstanding shares are owned by corporate insiders. The book value of Monogram Orthopaedics was now reported as 0.43. The company recorded a loss per share of 0.47. Monogram Orthopaedics had not issued any dividends in recent years. To find out more about Monogram Orthopaedics Common contact the company at 512 399 2656 or learn more at https://www.monogramorthopedics.com.Besides selling stocks to institutional investors, Monogram Orthopaedics also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Monogram Orthopaedics' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Monogram Orthopaedics' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Monogram Orthopaedics Quarterly Liabilities And Stockholders Equity |
|
About 34.0% of Monogram Orthopaedics Common are currently held by insiders. Unlike Monogram Orthopaedics' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Monogram Orthopaedics' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Monogram Orthopaedics' insider trades
Monogram Orthopaedics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Monogram Orthopaedics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Monogram Orthopaedics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Monogram Orthopaedics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Knape Noel six days ago Acquisition by Knape Noel of 288461 shares of Monogram Orthopaedics at 2.08 subject to Rule 16b-3 | ||
Merriweather Alfred G over a month ago Acquisition by Merriweather Alfred G of 100000 shares of Monogram Orthopaedics at 1.88 subject to Rule 16b-3 | ||
Mendlein John over two months ago Acquisition by Mendlein John of 20000 shares of Monogram Orthopaedics at 1.88 subject to Rule 16b-3 | ||
Knape Noel over six months ago Acquisition by Knape Noel of 25000 shares of Monogram Orthopaedics at 2.33 subject to Rule 16b-3 | ||
Goddard Noel over a year ago Monogram Orthopaedics exotic insider transaction detected |
Monogram Orthopaedics Corporate Filings
F4 | 26th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 14th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 8th of November 2024 Other Reports | ViewVerify | |
| 30th of October 2024 Other Reports | ViewVerify |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Monogram Orthopaedics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monogram Orthopaedics. If investors know Monogram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monogram Orthopaedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.012 | Return On Assets (0.61) | Return On Equity (1.22) |
The market value of Monogram Orthopaedics is measured differently than its book value, which is the value of Monogram that is recorded on the company's balance sheet. Investors also form their own opinion of Monogram Orthopaedics' value that differs from its market value or its book value, called intrinsic value, which is Monogram Orthopaedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monogram Orthopaedics' market value can be influenced by many factors that don't directly affect Monogram Orthopaedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monogram Orthopaedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Monogram Orthopaedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monogram Orthopaedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.